Menu

Pharmaceuticals

Real-World Evidence Shows Oral INVOKANA® 300 mg Demonstrates Comparable A1C Reduction and Control to Injectable GLP-1 Receptor Agonists

, ,

Patients Taking INVOKANA® 300 mg Were Significantly Less Likely to Discontinue the Medication or Be Prescribed a New Antihyperglycemic Agent Note: This release corresponds to American Association of Clinical Endocrinologists Annual Scientific & Clinical Congress Poster No. 290 TITUSVILLE, NJ, May 5, 2017 – Janssen Pharmaceuticals, Inc. (Janssen), today announced real-world evidence showing people with […]

Allergan to Present New Data at the 2017 American College of Obstetricians and Gynecologists (ACOG) Clinical and Scientific Meeting in San Diego

, , ,

DUBLIN, May 4, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company in women’s healthcare, will present new data from its women’s healthcare portfolio, at the annual American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting in San Diego, May 6-9. The scheduled times (noted in local Pacific Time) […]

Johnson & Johnson and the United Nations Foundation Launch the Fifth Annual Global Moms Relay to Improve the Health and Wellbeing of Families Worldwide

, ,

Global Moms Relay Kicks Off with One-of-a-Kind Summit to Share Ideas, Inspire Action and Tackle Challenges Facing Moms Around the World (New York, New York – May 4, 2017) – Today marks the start of the fifth-annual Global Moms Relay, an annual campaign co-created by Johnson & Johnson and the United Nations Foundation to improve […]

Allergan Successfully Completes ZELTIQ® Aesthetics Acquisition

, , ,

Acquisition Adds Best-in-Class Body Contouring Business to Allergan’s World-Class Facial Aesthetics, Plastic Surgery & Regenerative Medicine Businesses Acquisition of CoolSculpting,® Sales Leader in Fast-Growing, Cash Pay Body Contouring Segment, is Immediately Accretive to Allergan DUBLIN, April 28, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced it has successfully completed […]

Supervisory Board of Bayer AG extends service contract of CFO Johannes Dietsch to the end of May 2018

, , ,

Leverkusen, April 27, 2017 – The Supervisory Board of Bayer AG has extended the current service contract of Chief Financial Officer Johannes Dietsch (55) until May 31, 2018. After that date, Johannes Dietsch will be leaving the company at his own request. “Designing the detailed financing of the Monsanto acquisition and the ongoing approval and […]

Abbott Introduces Science-based Nutrition Drinks to Help Patients Have a Better Recovery from Surgery

, , ,

Research shows that staying nourished in the days and hours prior to a procedure can help patients prepare for and recover from surgery New Ensure® Surgery Immunonutrition Shake and Ensure® Pre-Surgery Clear Nutrition Drink are designed for hospitals implementing surgical guidelines for enhancing patient recovery ABBOTT PARK, Ill., April 26, 2017 /PRNewswire/ — More than […]

Allergan Granted Marketing Authorization by the FDA for TrueTear™, the First Intranasal Neurostimulating Device Proven to Temporarily Increase Tear Production

, , ,

First-of-its-Kind Product Further Adds to Allergan’s Robust Eye Care Portfolio DUBLIN, April 25, 2017 /PRNewswire/ — Allergan plc, (NYSE: AGN) today announced that it has been granted marketing authorization from the U.S. Food and Drug Administration (FDA) for TrueTear™ Intranasal Tear Neurostimulator, the first and only FDA-cleared device developed to temporarily increase tear production during […]

Johnson & Johnson Human Performance Institute Launches Corporate Athlete® Resilience Program

, ,

Training solution addresses corporate burnout, managing uncertainty, stress awareness, and strategic recovery NEW BRUNSWICK, N.J., April 25, 2017 – Johnson & Johnson Human Performance Institute (JJHPI) announced the launch of Corporate Athlete® Resilience, a new in-depth training solution that takes a different approach to stress management by supporting an individual’s ability to redefine and strategically […]

Allergan Partners with TARGET PharmaSolutions to Advance NASH Research

, , ,

Five-Year Study to Enroll 15,000 Adults and Children with NAFLD or NASH NASH Fastest Growing Cause of Liver Cancer and Liver Transplant in the U.S. DUBLIN, April 20, 2017 /PRNewswire/ — Allergan, a leading global biopharmaceutical company, announced today that it will collaborate with TARGET PharmaSolutions, a clinical data company focused on real world evidence, […]

«‹ 3 4 5 6›»